Philip Morris cuts annual profit outlook citing cost pressures and weak pricing

• The company lowered its 2026 adjusted earnings per share forecast, with the CEO noting that cost offsets are limited in the current competitive environment where price increases cannot be fully passed to consumers
• Philip Morris views recent FDA enforcement actions against unauthorized vaping and nicotine products as a 'net positive' that reduces regulatory uncertainty for its Zyn nicotine pouch brand
• The company is launching a lower-priced version of Zyn to reduce its price premium and improve competitiveness, while price increases in Japan driven by excise tax changes have weighed on category growth

Philip Morris Cuts 2026 Profit Outlook Amid Cost Pressures

Key Developments:

Philip Morris International slashed its 2026 adjusted earnings per share forecast on June 2, marking the second downward revision since April. CEO Jacek Olczak cited multiple headwinds including elevated energy costs stemming from the Iran conflict, unfavorable currency fluctuations, and challenging pricing dynamics as consumers curtail spending.

Strategic Response:

The company is introducing a lower-priced version of its Zyn nicotine pouches to reduce its price premium and enhance competitiveness in an increasingly crowded market. However, Olczak warned that price increases are "not always fully absorbed" in the current competitive environment, limiting the company's ability to offset rising costs through pricing power.

Regulatory and Market Factors:

The CEO viewed recent U.S. FDA enforcement actions against unauthorized vaping and nicotine pouch products as a "net positive," reducing regulatory uncertainty for its Zyn brand and potentially supporting category growth. In Japan, recent excise tax-driven price increases have dampened overall category growth, though Philip Morris's market share remains largely intact.

Business Context:

Philip Morris has been aggressively expanding its smoke-free product portfolio, including the IQOS heated tobacco device, vapes, and oral nicotine pouches like Zyn. This strategic pivot comes as the company navigates intensifying competition in traditional tobacco products and seeks growth in alternative nicotine delivery systems.

Market Implications:

The profit warning signals margin compression across the tobacco industry as companies struggle to balance cost inflation with pricing discipline in price-sensitive markets. The move toward value-oriented products suggests sustained consumer pressure even in traditionally resilient categories.